🧬 This Week in Immunology: Ulcerative Colitis Breakthroughs, Wearable Flare Detection, and Global Oncology Expansion
Stay up to date with the most important immunology developments—spanning precision IBD therapies, AI-driven wearables, and high-impact clinical trial news:
💥 OSE Immunotherapeutics advances global expansion in inflammation and cancer immunotherapy
🥦 Biomerica’s inFoods® IBS test shows FDA-benchmark success for pain reduction
🧪 ProPhase Labs launches advisory board for BE-Smart™ esophageal test
🧠 Israeli researchers uncover neutrophils’ dual role in breast cancer progression
🧭 Oxford identifies TRM17 cells as IL-17 source in spondyloarthritis
⌚ NimBio unveils the Inflammometer™—a real-time, wearable inflammation detector
🌐 Astria Therapeutics to present promising HAE and dermatitis data at EAACI 2025
🤱 Japanese study finds no cesarean-linked allergy risk in children
📢 Stay Ahead in Immunology Research!
✅ Like, share, and subscribe for weekly updates on the latest in immunology and autoimmune diseases
#UlcerativeColitis #ImmunoOncology #IBS #Biomerica #PrecisionMedicine #BarrettsEsophagus #ProPhaseLabs #BreastCancerResearch #TNBC #Neutrophils #Spondyloarthritis #IL17 #OxfordResearch #IBD #WearableTech #Inflammation #AstriaTherapeutics #HAE #AtopicDermatitis #AllergyResearch #CesareanBirth #ClinicalTrials #LucidQuest #ImmunologyUpdates